simeprevir

8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St
Sat, 09/3/16 - 12:17 pm
FDA
Achillion
odalasvir
AL-335
simeprevir
Amarin
Vascepa
Array Biopharma
binimetinib
Mast Therapeutics
vepoloxamer
Novavax
Threshold Pharmaceuticals
tarloxotinib
J&J, Medivir Win U.S. FDA Approval for Hepatitis C Pill
Bloomberg
Sat, 11/23/13 - 12:49 pm
JNJ
Medvir
hepatitis C
hepatitis
Olysio
simeprevir
Gilead Vs. Challengers In The Hepatitis C Race
Seeking Alpha
Thu, 11/7/13 - 09:52 am
Gilead
hepatitis C
AbbVie
Bristol-Myers Squibb
JNJ
Merck
simeprevir
sofosbuvir
daclatasvir
Why Gilead's Sofosbuvir Is Better Than J&J's Simeprevir
Motley Fool
Tue, 10/29/13 - 09:21 am
Gilead
sofosbuvir
JNJ
hepatitis C
simeprevir
J&J-Medivir Hepatitis C Pills Wins U.S. Panel Backing
Bloomberg
Thu, 10/24/13 - 06:04 pm
FDA
JNJ
Medivir
hepatitis C
simeprevir
J&J-Medivir’s Drug Works Against Hepatitis C
Bloomberg
Tue, 10/22/13 - 08:36 am
JNJ
Medivir
hepatitis C
simeprevir
FDA
J&J snaps up an NS5A inhibitor from GlaxoSmithKline for hep C cocktail
Fierce Biotech
Tue, 10/8/13 - 09:41 am
JNJ
NS5A Inhibitors
GSK
hepatitis C
simeprevir
GSK2336805
Inside HCV: An Interview with Janssen
Motley Fool
Thu, 06/13/13 - 10:54 am
hepatitis C
Janssen
Gilead
JNJ
Vertex
simeprevir
sofosbuvir
Idenix Pharma Initiates Phase II Study
Yahoo/Zacks
Sat, 06/1/13 - 12:06 pm
Idenix
hepatitis C
hepatitis
samatasvir
IDX719
simeprevir
TMC435
JNJ
[video]FDA Prioritizes New Hepatitis C Drug
Motley Fool
Tue, 05/14/13 - 09:04 am
FDA
JNJ
hepatitis C
simeprevir
Gilead-Medivir Hepatitis C Drug Clears Virus in Patients
Bloomberg
Mon, 03/4/13 - 10:59 am
hepatitis C
Gilead
Medivir
sofosbuvir
simeprevir
Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C
The Fly on the Wall
Thu, 11/1/12 - 10:05 am
Vertex
Janssen
hepatitis C
simeprevir
VX-135